Another Bioresorbable Stent Hits a Snag

(MedPage Today) -- A novel bioresorbable stent failed to meet the threshold for noninferiority compared with durable devices in the OPTIMIZE trial, and researchers suggested rising troponin use may have played a role.
The Svelte stent, designed...